+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection

Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection

Journal of Medical Virology 71(3): 376-384

There are several lines of evidence suggesting that specific vaccine therapy with a standard hepatitis B virus (HBV) vaccination reduces HBV replication. The aim of this study was to investigate the anti-viral mechanism of vaccine therapy in chronic hepatitis B patients. Nineteen patients were assigned to receive either vaccine therapy (n = 13) or no treatment as a control (n = 6). Vaccinated patients were analyzed for T cell proliferative responses specific for envelope antigen and cytokine production by antigen-specific T cells. ELISPOT and cytotoxicity assays also were carried out for limited blood samples. Serum HBV DNA levels decreased significantly at 3 months after completion of therapy and thereafter as compared to the baseline ones, and were significantly lower in vaccinated patients than in controls at 12 and 18 months after completion of therapy. Vaccination induced antigen-specific CD4+ T cell proliferative responses in four patients (30.8%). The production of high levels of interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) by antigen-specific T cells was found in six patients (46.0%) who showed significantly lower HBV DNA levels in serum at 6 (P = 0.04) and 18 months (P = 0.005) after completion of therapy than those without high levels of cytokine production. Vaccination did not induce antigen-specific CD8+ T cells or cytotoxic T cells. These results suggest that envelope-specific CD4+ T cells may control directly HBV replication by producing anti-viral cytokines rather than providing help for cytotoxic T cells in therapeutic vaccination against chronic HBV infection.

(PDF emailed within 0-6 h: $19.90)

Accession: 011918368

Download citation: RISBibTeXText

PMID: 12966542

DOI: 10.1002/jmv.10509

Related references

Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: Reversion by anti-viral treatment. Biochemical and Biophysical Research Communications 393(2): 331-337, 2010

Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection. Retrovirology 13(): 24-24, 2016

Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells. Current Opinion in Immunology 10(4): 444-449, 1998

Anti viral treatment of chronic hepatitis b virus infection 1. changes in viral markers with interferon combined with adenine arabinoside. Journal of Infectious Diseases 143(6): 772-783, 1981

High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments. Plos One 12(1): E0170028-E0170028, 2017

The prevention of early vaccinia virus induced cytopathic effects by inhibition of protein synthesis monkey kidney cells puromycin anti viral actinomycin d anti viral isatan beta thio semi carbazone anti viral para fluorophenyl alanine anti viral 5 fluorodeoxy uridine anti viral. Journal of General Virology 3(1): 51-61, 1968

Viral RNA induces type I interferon-dependent cytokine release and cell death in mesangial cells via melanoma-differentiation-associated gene-5: Implications for viral infection-associated glomerulonephritis. American Journal of Pathology 175(5): 2014-2022, 2010

Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapy. Alimentary Pharmacology & Therapeutics, 2018

Detection of Hepatitis C antibodies without viral transmission in Hepatitis C negative recipients receiving kidneys from Hepatitis C positive donors treated with Direct Acting Anti-Viral Therapy. Transplantation, 2017

Thymus dependent bone marrow dependent and null lymphocytes in chronic hemo dialysis and in hepatitis b surface antigen positive and chronic active viral hepatitis patients. Kidney International 8(6): 446, 1975

Newer anti viral agents comparative assays in vivo and in vitro rabbit herpes keratitis tri fluoro thymidine anti viral iododeoxy uridine anti viral methylaminodeoxy uridine anti viral cytosine arabinoside anti viral phagicin anti viral. Chemotherapy 13(3): 139-145, 1968

Treatment of active chronic hepatitis with 6 mercapto purine anti viral iii the therapeutic dose of 6 mercapto purine metab in relation to the effect on the metabolism of serum albumin and hepatic dna synthesis abstract human viral hepatitis. Gastroenterologia Japonica 2(4): 352-353, 1967

A study of the effect of some chemo therapeutic drugs on the foot and mouth disease virus in a tissue culture quinacrine hydro chloride anti viral bi phenyl glyoxal derivative anti viral 4 amino 7 chloro quinoline derivative anti viral mitomycin anti viral. Trudy Vsesoyuznogo Instituta Eksperimental'Noi Veterinarii: 77-279, 1967

Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection. Clinical Immunology 132(1): 43-54, 2009

Temporal pathogenesis of experimental neonatal woodchuck hepatitis virus infection: increased initial viral load and decreased severity of acute hepatitis during the development of chronic viral infection. Hepatology 32(4 Pt 1): 807-817, 2000